Citizens Are Not Fooled by Fake Statistics
What happened when the Argentine government lied about inflation numbers?
Clues to the Market When Mortgage Originators Delay Securitization
With high-quality borrowers hard to judge from afar, Alt-A market offers quiet signal on creditworthiness
Options Market Signals Scope of Federal Reserve Interventions
Traders see an implicit promise beyond specific asset purchases
Cause and Effect in the Complex World of Corporate Decision Making
As with scientific research, it’s hard to distinguish correlation from causation
Sales Promotions Influence People Beyond Purchasing Decisions
Exposure to discounts makes people impatient
Retailing Cross-Platform Win: A Pop-Up Store Boosts Online Sales
Alibaba finds a fresh twist on an old-school store is an effective marketing tool
Historical Case for Immigrants Sending Home More Than Money
France’s lower fertility rates spread to regions that sent the most emigrants to live there
Taking the Battle for Financial Literacy to Where the Eyeballs Are
Research by Bruce Carlin and Stephen Spiller suggests YouTube videos could help consumers make better money decisions
Does Better Corporate Disclosure Boost Markets?
Stronger financial reporting standards seem to mean more for growth of countries’ credit markets than their stock markets
Do Fair Disclosure Rules Lead to More or Less Information?
Managers, forced to inform a broader audience, choose not to gather information even for themselves
Credit Scores, Used to Predict Repayment, Can Restrain Economic Recovery
Rigid adherence to scoring systems can reduce consumer spending when it’s most needed
The Hidden Cost of Raising Corporate Taxes
Consumer spending falls — and vulnerable families take the biggest hit
Should Manufacturers Use Formal Procedures to Evaluate Alternative Materials?
Methods that weight efficacy, toxicity and cost improve understanding but provide no easy answers
Companies Sued for Securities Fraud Adopt More Conservative Accounting
The shift spreads through auditors to other clients, potentially clouding the financial information investors rely upon
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
College Completion and Your Genome (Don’t Get Too Excited)
It’s still early days in genetic research, though advances will aid study of educational attainment and, notably, disease